CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 3D Global Biotech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

3D Global Biotech Inc
21F-3, No.99, Section 1
Xintai 5th Road, Xizhi District
Phone: +886 226971270p:+886 226971270 NEW TAIPEI, 221  Taiwan Ticker: 68086808

Business Summary
3D Global Biotech Inc a biotechnology company mainly engaged in the development of medical materials for human reconstruction, focusing on the development of high-end medical equipment and biological printing technology. The Company mainly provides hard tissue reconstruction medical materials and soft tissue reconstruction medical materials. The hard tissue reconstruction medical materials mainly provide customized services for dental medical materials, original equipment manufacturer services for customized products of cranial implants, and orthopedics and dental reconstruction medical materials DGRA01: a-Former bone filling materials and the second-level medical equipment product of craniofacial jaw reconstruction medical materials DGRA03: SmileAlign transparent correction system. The soft tissue reconstruction medical materials mainly include bio-ink product DGRC02: 3D Bioture EX water gel stent.
(Source: N-30D)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, General Manager GengliangOu
Deputy General Manager RuiwenHuang 1/1/2024
Director Ming-HsienChen 11/19/2020 11/19/2020
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 33 (As of 12/31/2023)
Outstanding Shares: 76,809,000 (As of 7/31/2024)
Shareholders: 641
Stock Exchange: TPO
Fax Number: +886 226971272


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 21, 2024